基于药和脊柱跳跃百氧化1 (PRDX1) 抑制剂的小分子化合物的化分析
Ningying Zheng1, Huiting Tan1, Tianli Lai1
1The Marine Biomedical Research Institute of Guangdong Zhanjiang, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, Guangdong, China.
Journal of biomolecular structure & dynamics
|March 6, 2024
概括
研究人员选了超过20万个分子,以寻找针对PRDX1的新药,这是一种参与癌症生长的蛋白质. 化合物6和9显示稳定地与PRDX1结合,表明它们有可能作为癌症治疗的竞争性抑制剂.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 计算机化药物发现技术
背景情况:
- Peroxiredoxins (PRDX) 在癌症的进展中至关重要,特别是结肠直肠癌.
- 现有的PRDX1抑制剂缺乏临床应用,需要新的治疗策略.
研究的目的:
- 为了确定可以抑制Peroxiredoxin 1 (PRDX1) 活性的新型小分子.
- 评估潜在的PRDX1抑制剂的药物相似性和结合稳定性.
主要方法:
- 使用分子对接和药模拟对210,331个小分子进行虚拟选.
- 使用ROC曲线分析进行基于结构的药型号验证.
- 用于稳定性评估的ADMET属性预测,分子动力学和MM-PBSA计算.
主要成果:
- 通过分子对接识别了13个得分最高的化合物.
- 根据药理学模型得分和骨架跳跃,选择了九种化合物.
- 过到三个具有有利ADMET特性的化合物.
- 化合物6和9与PRDX1蛋白具有稳定的结合复合体.
结论:
- 化合物6和9显示出作为PRDX1.1的竞争性抑制剂的显著潜力.
- 这些化合物可以被开发成用于PRDX1相关癌症的新型治疗剂.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.5K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.0K
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
718
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
718
Peroxisomes
12.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.3K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
